145 related articles for article (PubMed ID: 21050726)
1. Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.
Cosgrove KP; Tellez-Jacques K; Pittman B; Petrakis I; Baldwin RM; Tamagnan G; Seibyl J; Kosten T; Staley JK
Psychiatry Res; 2010 Dec; 184(3):192-5. PubMed ID: 21050726
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and serotonin transporter availability during acute alcohol withdrawal: effects of comorbid tobacco smoking.
Cosgrove KP; Krantzler E; Frohlich EB; Stiklus S; Pittman B; Tamagnan GD; Baldwin RM; Bois F; Seibyl JP; Krystal JH; O'Malley SS; Staley JK
Neuropsychopharmacology; 2009 Sep; 34(10):2218-26. PubMed ID: 19440191
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in diencephalon serotonin transporter availability in major depression.
Staley JK; Sanacora G; Tamagnan G; Maciejewski PK; Malison RT; Berman RM; Vythilingam M; Kugaya A; Baldwin RM; Seibyl JP; Charney D; Innis RB
Biol Psychiatry; 2006 Jan; 59(1):40-7. PubMed ID: 16139815
[TBL] [Abstract][Full Text] [Related]
5. The association between availability of serotonin transporters and time to relapse in heroin users: a two-isotope SPECT small sample pilot study.
Lin SH; Chen KC; Lee SY; Yao WJ; Chiu NT; Lee IH; Chen PS; Yeh TL; Liao MH; Lu RB; Yang YK
Eur Neuropsychopharmacol; 2012 Sep; 22(9):647-50. PubMed ID: 22335891
[TBL] [Abstract][Full Text] [Related]
6. Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.
Kim SE; Choi JY; Choe YS; Choi Y; Lee WY
J Nucl Med; 2003 Jun; 44(6):870-6. PubMed ID: 12791812
[TBL] [Abstract][Full Text] [Related]
7. Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
Pirker W; Asenbaum S; Hauk M; Kandlhofer S; Tauscher J; Willeit M; Neumeister A; Praschak-Rieder N; Angelberger P; Brücke T
J Nucl Med; 2000 Jan; 41(1):36-44. PubMed ID: 10647603
[TBL] [Abstract][Full Text] [Related]
8. Topography of dopamine transporter availability in progressive supranuclear palsy: a voxelwise [123I]beta-CIT SPECT analysis.
Seppi K; Scherfler C; Donnemiller E; Virgolini I; Schocke MF; Goebel G; Mair KJ; Boesch S; Brenneis C; Wenning GK; Poewe W
Arch Neurol; 2006 Aug; 63(8):1154-60. PubMed ID: 16908744
[TBL] [Abstract][Full Text] [Related]
9. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates.
Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S
Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes of dopamine transporters in heroin users during abstinence.
Xu S; Liu Y; Li Y; Deng Y; Huang Y; Yuan J; Lv R; Wang Y; Zhang G; Guo Z; Han M; Liu X; Fu D
Psychopharmacology (Berl); 2015 Sep; 232(18):3391-401. PubMed ID: 26096461
[TBL] [Abstract][Full Text] [Related]
11. SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT.
Abi-Dargham A; Gandelman MS; DeErausquin GA; Zea-Ponce Y; Zoghbi SS; Baldwin RM; Laruelle M; Charney DS; Hoffer PB; Neumeyer JL; Innis RB
J Nucl Med; 1996 Jul; 37(7):1129-33. PubMed ID: 8965183
[TBL] [Abstract][Full Text] [Related]
12. Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients.
Zaaijer ER; van Dijk L; de Bruin K; Goudriaan AE; Lammers LA; Koeter MW; van den Brink W; Booij J
Psychopharmacology (Berl); 2015 Jul; 232(14):2597-607. PubMed ID: 25757673
[TBL] [Abstract][Full Text] [Related]
13. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
[TBL] [Abstract][Full Text] [Related]
14. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
[TBL] [Abstract][Full Text] [Related]
16. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
Ruhé HG; Booij J; Reitsma JB; Schene AH
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
[TBL] [Abstract][Full Text] [Related]
17. The association between heroin expenditure and dopamine transporter availability--a single-photon emission computed tomography study.
Lin SH; Chen KC; Lee SY; Chiu NT; Lee IH; Chen PS; Yeh TL; Lu RB; Chen CC; Liao MH; Yang YK
Psychiatry Res; 2015 Mar; 231(3):292-7. PubMed ID: 25659472
[TBL] [Abstract][Full Text] [Related]
18. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.
Riikonen RS; Nokelainen P; Valkonen K; Kolehmainen AI; Kumpulainen KI; Könönen M; Vanninen RL; Kuikka JT
Biol Psychiatry; 2005 Jun; 57(12):1565-72. PubMed ID: 15953494
[TBL] [Abstract][Full Text] [Related]
19. Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.
Parkinson Study Group
JAMA; 2002 Apr; 287(13):1653-61. PubMed ID: 11926889
[TBL] [Abstract][Full Text] [Related]
20. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
